Wealthcare Advisory Partners’s State Street SPDR S&P China ETF GXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9M Buy
33,465
+2,350
+8% +$220K 0.05% 276
2026
Q1
$2.9M Sell
31,115
-451
-1% -$44.6K 0.06% 282
2025
Q4
$3.06M Buy
31,566
+512
+2% +$51.7K 0.06% 265
2025
Q3
$3.26M Sell
31,054
-405
-1% -$38.7K 0.07% 237
2025
Q2
$2.75M Sell
31,459
-8,154
-21% -$685K 0.06% 260
2025
Q1
$3.41M Buy
+39,613
New +$3.25M 0.09% 189
2021
Q2
Sell
-17
Closed -$2K 1087
2021
Q1
$2K Buy
+17
New +$2.39K ﹤0.01% 1874

Other funds holding GXC

Wealthcare Advisory Partners's GXC Position: Q2 2026 in Review

Wealthcare Advisory Partners increased its State Street SPDR S&P China ETF (GXC) stake by 7.6% in Q2 2026, buying an estimated $220K and bringing the position to 33,465 shares worth $2.9M. The position accounts for 0.05% of the portfolio, ranked #276.

Wealthcare Advisory Partners first reported a position in GXC in Q1 2021 and has held it in 7 quarters since. The position peaked at $3.41M in Q1 2025. 10 funds tracked by Wall St. Rank hold GXC as of Q2 2026.

  • Wealthcare Advisory Partners held 33,465 shares of State Street SPDR S&P China ETF worth $2.9M as of Q2 2026.
  • Wealthcare Advisory Partners bought 2,350 State Street SPDR S&P China ETF shares in Q2 2026, an estimated $220K.
  • State Street SPDR S&P China ETF made up 0.05% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #276 holding.
  • Wealthcare Advisory Partners first reported a position in State Street SPDR S&P China ETF in Q1 2021 and has held it in 7 quarters since.
  • Wealthcare Advisory Partners's State Street SPDR S&P China ETF position peaked at $3.41M in Q1 2025.
  • 10 funds tracked by Wall St. Rank held State Street SPDR S&P China ETF as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.